You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: April 5, 2026

DEHYDRATED ALCOHOL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


DrugPatentWatch® Litigation and Generic Entry Outlook for Dehydrated Alcohol

A generic version of DEHYDRATED ALCOHOL was approved as dehydrated alcohol by ACCORD HLTHCARE on June 23rd, 2025.

  Start Trial

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for DEHYDRATED ALCOHOL?
  • What are the global sales for DEHYDRATED ALCOHOL?
  • What is Average Wholesale Price for DEHYDRATED ALCOHOL?
Summary for DEHYDRATED ALCOHOL
US Patents:0
Applicants:5
NDAs:5

US Patents and Regulatory Information for DEHYDRATED ALCOHOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Accord Hlthcare DEHYDRATED ALCOHOL dehydrated alcohol SOLUTION;INTRA-ARTERIAL 217845-001 Jun 23, 2025 AP RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Xgen Pharms DEHYDRATED ALCOHOL dehydrated alcohol SOLUTION;INTRA-ARTERIAL 219400-001 Jun 23, 2025 AP RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Breckenridge DEHYDRATED ALCOHOL dehydrated alcohol SOLUTION;INTRA-ARTERIAL 219444-001 Jun 23, 2025 AP RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Ingenus Pharms Llc DEHYDRATED ALCOHOL dehydrated alcohol SOLUTION;INTRA-ARTERIAL 219569-001 Jul 9, 2025 AP RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Royal Pharms DEHYDRATED ALCOHOL dehydrated alcohol SOLUTION;INTRAVENOUS 214988-001 Oct 23, 2025 RX Yes Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Dehydrated Alcohol: Investment Scenario, Market Dynamics, and Financial Trajectory

Last updated: February 3, 2026

Summary

Dehydrated alcohol, or anhydrous ethanol, is a high-purity alcohol primarily used in pharmaceutical applications, sanitizers, cosmetics, and industrial processes. The global market for dehydrated alcohol is experiencing growth driven by increased demand for disinfectants amid the ongoing emphasis on hygiene and the expanding pharmaceutical sector. This report analyzes current market dynamics, investment prospects, and financial trajectories for companies involved in dehydrated alcohol production and commercialization.


What Is Dehydrated Alcohol and Its Key Specifications?

Attribute Specification
Chemical Composition Ethanol (C₂H₅OH) with ≥ 99.5% purity
Production Methods Fermentation and catalytic dehydration branch
Applications Pharmaceuticals, hand sanitizers, cosmetics, industrial solvents
Manufacturing Locations Predominantly USA, EU, India, China
Regulatory Standards WHO GMP, USP, EP, BP standards

Market Dynamics: Drivers and Restraints

Key Market Drivers

Driver Details Impact
Surge in Demand for Sanitizers COVID-19 pandemic led to a significant increase in demand for hand sanitizers, predominantly containing hydrated alcohol (>70%) High growth in health sector
Expansion in Pharmaceutical Sector Growth in global pharmaceutical manufacturing, requiring dehydrated alcohol for synthesis and formulation Sustained industrial demand
Stringent Hygiene Regulations Governments' increased regulation on cleanliness standards in healthcare settings Regulatory tailwinds for sanitizers & disinfectants
Rising Use in Cosmetics Use as a solvent and antiseptic in cosmetic products Market diversification

Market Restraints

Restraint Details Impact
Environmental Regulations Stricter rules on volatile organic compounds (VOCs) emissions affecting production Increased compliance costs
Supply Chain Disruptions COVID-19 and geopolitical factors impacting raw material supply Chains Price volatility, supply gaps
High Production Costs Energy-intensive dehydration process, fluctuating feedstock prices Margins under pressure

Market Size and Growth Trajectory

Market Metrics Data/Forecasts Sources
Global Market Size (2022) $2.3 billion Grand View Research[1]
Projected CAGR (2023-2030) 4.5% Future Market Insights[2]
Key Regional Markets (2022) North America (35%), Europe (25%), Asia-Pacific (30%), ROW (10%) Industry Reports[1][2]
Forecast Market Size (2030) $3.4 billion Based on CAGR[2]

Investment Opportunities and Risks

Opportunities

  • Biopharmaceutical Partnerships: Collaborations for specialized dehydration processes producing pharmaceutical-grade alcohol.
  • Emerging Markets Expansion: Increased demand in developing countries driven by healthcare infrastructure.
  • Technology Innovations: Adoption of energy-efficient dehydration technologies like membrane separation or advanced distillation.
  • Product Diversification: Developing specific derivatives such as denatured alcohol, beverage ethanol, or biofuels.

Risks

  • Regulatory Changes: Stringent environmental policies may increase operational costs or restrict certain production methods.
  • Raw Material Price Fluctuations: Feedstock ethanol prices influenced by agriculture policies and energy markets.
  • Competitive Landscape: Price competition among manufacturers, especially in low-cost regions.

Financial Trajectory: Cost, Revenue, and Profitability Analysis

Cost Structure

Cost Component Approximate Percentage Description
Raw Materials (ethanol, water, catalysts) 40% Dominant operational cost
Energy (electricity, heat) 25% Dehydration process is energy-intensive
Capital Expenditure (CapEx) 15% Plant setup, dehydration equipment
Labor and Overhead 10% Plant operations, quality control
Regulatory Compliance 5% Permits, testing, standards
Distribution & Logistics 5% Cost varies with region

Revenue Streams and Pricing

Segment Pricing (USD/Liter) Volume Forecast (2023-2030) Market Share
Pharmaceutical Grade 3.00 – 4.50 Growing, 5-10% annual increase 40%
Sanitizer & Disinfectants 2.00 – 3.50 Rapid growth, 8-12% annual increase 35%
Cosmetic & Industrial Use 1.50 – 2.50 Moderate growth, 3-5% annual increase 15%
Denatured Alcohol 2.00 – 3.00 Stable, niche applications 10%

Profitability Outlook (Estimates)

Parameter 2023 2025 2030
Average Gross Margin 20-25% 25-30% 30-35%
EBITDA Margin 10-15% 15-20% 20-25%
Net Profit Margin 5-10% 10-15% 15-20%
Forecast Revenue $1.0 billion $1.8 billion $3.4 billion

(Assuming typical profit margins for specialized chemical manufacturing alongside market expansion growth)


Comparison with Alternative Alcohols and Derivatives

Parameter Dehydrated Alcohol Isopropanol Methanol
Purity Standards ≥ 99.5% ≥ 99% ≥ 99%
Primary Uses Pharmaceuticals, sanitizers Disinfectants, cleaning agents Industrial solvent, fuel
Production Complexity High (energy-intensive dehydration) Moderate Moderate
Market Size (2022) $2.3 billion $1.2 billion $870 million
Growth Rate (2023-2030) 4.5% CAGR 3.8% CAGR 3.2% CAGR

Regulations and Policy Landscape

Region Key Regulations Implications for Dehydrated Alcohol Industry
United States EPA VOC regulations, FDA for pharmaceutical-use standards Stricter emissions rules; compliance costs increase
European Union REACH, CLP Regulations, Good Manufacturing Practice (GMP) Higher standards; push for cleaner, energy-efficient processes
India BIS standards, environmental controls Growing demand, but regulatory and infrastructure hurdles
China Environmental policies, industrial safety standards Market expansion with regulatory compliance costs

Future Outlook and Investment Strategics

  • Target innovative dehydration technologies to reduce energy consumption and environmental footprint.
  • Establish strategic industry partnerships in pharma and healthcare segments.
  • Expand production capacity in high-growth regions like Asia-Pacific.
  • Invest in R&D to develop differentiated product grades (e.g., denatured alcohol with customized additives).
  • Monitor regulatory developments to adapt compliance strategies proactively.

Key Takeaways

  • The dehydrated alcohol market is projected to grow at a compound annual rate of 4.5% through 2030, driven by increased demand in sanitation, pharmaceuticals, and cosmetics.
  • Investment opportunities exist primarily in emerging markets, innovation in dehydration technology, and product diversification.
  • High capital and operational costs pose barriers, but profit margins are expected to improve with technological innovations and increased scale.
  • Regulatory compliance is a critical factor influencing production costs, especially concerning emissions and quality standards.
  • Competitive differentiation hinges on energy-efficient production processes, strict adherence to quality standards, and flexible supply chains.

FAQs

1. What are the key factors influencing investment in dehydrated alcohol manufacturing?
Market growth driven by hygiene and health sectors, technological innovation, regulatory landscape, and global demand fluctuations are primary drivers.

2. How do dehydration technologies impact costs and environmental compliance?
Advanced dehydration technologies like membrane separation reduce energy costs and emissions, improving sustainability and compliance.

3. Which regions offer the highest growth potential?
Asia-Pacific, particularly China and India, present significant opportunities due to expanding pharmaceutical and sanitation markets.

4. What are the main challenges for new entrants in this market?
High capital requirements, regulatory compliance, raw material sourcing, and access to advanced dehydration technology.

5. How does the market compare with alternative alcohols?
Dehydrated alcohol offers higher purity and pharmaceutical relevance but faces competition from other disinfectant alcohols like isopropanol, which have broader industrial applications.


References

[1] Grand View Research, "Dehydrated Alcohol Market Size & Trends," 2022.
[2] Future Market Insights, "Global Anhydrous Ethanol Market Outlook," 2023.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.